Prosecution Insights
Last updated: October 02, 2026

Clariant International Ltd.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

13 pending office actions • 6 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days

Analysis

Clariant International Ltd. is currently navigating 12 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are spread across 12 distinct examiners, showing that each pending matter is assigned to a different official. This distribution requires a broad prosecution strategy that accounts for the varied perspectives of 12 different individuals within the patent office, as no examiner's habits will define the portfolio's success.

The portfolio spans 6 distinct art units, indicating that the company's biotechnological and pharmaceutical interests are technically diverse. Nathan W Schlientz is the busiest examiner, though he holds 1 pending action. This lack of concentration among examiners suggests that no official's historical data will dominate the portfolio's overall success rate. With 12 pending office actions across 6 art units, the company faces a complex regulatory landscape that demands expertise across multiple pharmaceutical classifications.

The presence of 12 distinct examiners for the pending actions is a notable characteristic, suggesting that the company's filings are not being funneled to a specific group of officials. Practitioners should prepare for a range of examiner behaviors, as each official may have unique approaches to biotechnology claims. The 6 distinct art units involved further highlight the technical breadth of the company's current patenting efforts, making it essential to monitor trends across a significant portion of the USPTO's pharmaceutical divisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

13
Total Pending OAs
10
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (85%)
2
Medium (15%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (15%)
§103 only2 (15%)
Multi-statute (no §101)9 (69%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
54% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
6
Business / Other
46% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

130 h
Manual time on pending OAs
26 h
Time saved (low, 20%)
46 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SCHLIENTZ, NATHAN W 1 41.3% -18.9%
PO, MING CHEUNG 1 37.7% +13.7%
GULLEDGE, BRIAN M 1 55.8% +26.1%
HINES, LATOSHA D 1 51.2% +21.7%
SPAINE, ROBERT FRANKLIN 1 75.0% +0.0%
PAGANO, ALEXANDER R 1 78.7% +11.3%
REUTHER, ARRIE L 1 70.2% +12.3%
FADHEL, ALI Z 1 76.7% +8.8%
KUMAR, SRILAKSHMI K 1 49.7% +15.5%
STEINKE, SEAN JAMES 1 12.5% +42.9%

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18030176 Compositions Comprising Silybum Marianum Extract As A Senotherapeutic Agent LAZARO, DOMINIC 3d overdue
18688795 Prunella vulgaris extract and use thereof SPAINE, ROBERT FRANKLIN 84d
19064820 FATTY ACID DERIVATIVES FOR USE AS HERBICIDES SCHLIENTZ, NATHAN W —
18895632 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds PO, MING CHEUNG —
18839496 COMPOSITIONS COMPRISING PIROCTONE OLAMINE GULLEDGE, BRIAN M —
18718546 SHELL CATALYST FOR PRODUCING ALKENYL CARBOXYLIC ACID ESTERS HAVING AN IMPROVED PD AND AU DISTRIBUTION HINES, LATOSHA D —
18573548 BIO-BASED ISETHIONATE COMPOUNDS PAGANO, ALEXANDER R —
18549584 Process and System for Preparing a Target Compound FADHEL, ALI Z —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18895632 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds PO, MING CHEUNG —
18839496 COMPOSITIONS COMPRISING PIROCTONE OLAMINE GULLEDGE, BRIAN M —
18718546 SHELL CATALYST FOR PRODUCING ALKENYL CARBOXYLIC ACID ESTERS HAVING AN IMPROVED PD AND AU DISTRIBUTION HINES, LATOSHA D —
18573548 BIO-BASED ISETHIONATE COMPOUNDS PAGANO, ALEXANDER R —
18562248 Universal Dispersant For Inorganic And Organic Pigments REUTHER, ARRIE L —
18200036 WATER-GAS SHIFT REACTION CATALYSTS KUMAR, SRILAKSHMI K —
18032856 Opacifier Compositions STEINKE, SEAN JAMES —

Top Art Units

Art UnitApps
1738 2
1655 1
1692 1
1619 1
1765 1
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19064820 FATTY ACID DERIVATIVES FOR USE AS HERBICIDES SCHLIENTZ, NATHAN W — §102§103 Non-Final OA — Pending Feb 27, 2025
18895632 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds PO, MING CHEUNG — §101§103 Non-Final OA — Pending Sep 25, 2024
18839496 COMPOSITIONS COMPRISING PIROCTONE OLAMINE GULLEDGE, BRIAN M — §103§112 Non-Final OA — Pending Aug 19, 2024
18718546 SHELL CATALYST FOR PRODUCING ALKENYL CARBOXYLIC ACID ESTERS HAVING AN IMPROVED PD AND AU DISTRIBUTION HINES, LATOSHA D — §102§103§112 Non-Final OA — Pending Jun 11, 2024
18688795 Prunella vulgaris extract and use thereof SPAINE, ROBERT FRANKLIN 1655 §101§103§112 Non-Final OA 84d Pending Mar 04, 2024
18573548 BIO-BASED ISETHIONATE COMPOUNDS PAGANO, ALEXANDER R — §103§112 Non-Final OA — Pending Dec 22, 2023
18562248 Universal Dispersant For Inorganic And Organic Pigments REUTHER, ARRIE L — §103 Final Rejection — Pending Nov 17, 2023
18549584 Process and System for Preparing a Target Compound FADHEL, ALI Z 1692 §103§112 Non-Final OA — Pending Sep 07, 2023
18200036 WATER-GAS SHIFT REACTION CATALYSTS KUMAR, SRILAKSHMI K 1738 §103§112 Final Rejection — Pending May 22, 2023
18032856 Opacifier Compositions STEINKE, SEAN JAMES 1619 §103§112 Non-Final OA — Pending Apr 20, 2023
18032474 Process For Preparing Polyether Alcohols Having A Low Metal Ion Content DU, SURBHI M 1765 §103 Final Rejection 30d Pending Apr 18, 2023
18030176 Compositions Comprising Silybum Marianum Extract As A Senotherapeutic Agent LAZARO, DOMINIC 1611 §102§112 Non-Final OA 3d overdue Pending Apr 04, 2023
18018283 CATALYST FOR AMMONIA SYNTHESIS WITH IMPROVED ACTIVITY PIRO, NICHOLAS ANTHONY 1738 §102§103 Non-Final OA — Pending Jan 27, 2023

Managing Clariant International Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month